Induction in vitro of reversible immunosuppression and inhibition of B cell receptor regeneration by defined metabolites of cyclophosphamide

No abstract is available for this paper.

• Publication year

  1979

• Venue

  European Journal of Immunology

• Publication date

  1979-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/eji.1830090105PMID 374091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.

  1978cited by this paper
• Cyclophosphamide inhibited B cell receptor regeneration as a basis for drug-induced tolerance

  1978cited by this paper
• Drug‐promoted B cell tolerance induction: a selective activity of cyclophosphamide dependent on the tolerogenicity of thymus‐independent antigens

  1978cited by this paper
• The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.

  1978cited by this paper
• Influence of molecular structure on the tolerogenicity of bacterial dextrans. IV. Epitope size recognition and genetic resistance to alpha (1 leads to 3) glucosyl tolerance induction by dextran B1355.

  1977cited by this paper
• Mechanisms of B cell tolerance

  1977cited by this paper
• Influence of molecular structure on the tolerogenicity of bacterial dextrans

  1977cited by this paper
• Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.

  1976cited by this paper
• Antigen-induced aggregation and modulation of receptors on hapten- specific B lymphocytes

  1976cited by this paper
• The Mode of Action of Immunosuppressive Agents

  1976cited by this paper
• Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.

  1976cited by this paper
• Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self

  1975cited by this paper
• Receptor-mediated inactivation of early B lymphocytes

  1975cited by this paper
• Studies on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and related compounds.

  1975cited by this paper
• The mode of action of immunosuppressive agents.

  1975cited by this paper
• Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.

  1974cited by this paper
• Induction of B cell tolerance to polysaccharides by exhaustive immunization and during immunosuppression with cyclophosphamide

  1974cited by this paper
• Studies on immunological paralysis. IX. The immunogenicity and tolerogenicity of levan (polyfructose) in mice.

  1972cited by this paper
• A QUANTITATIVE ASSAY FOR THE PROGENITORS OF BONE MARROW-ASSOCIATED LYMPHOCYTES

  1972cited by this paper
• Studies on immunological paralysis: VI. Thymic-independence of tolerance and immunity to type III pneumococcal polysaccharide

  1971cited by this paper
• On the mechanism of immunological tolerance in cyclophosphamide-treated mice.

  1970cited by this paper
• STUDIES ON CYCLOPHOSPHAMIDE-INDUCED TOLERANCE TO SHEEP ERYTHROCYTES

  1967cited by this paper
• Analysis of Differentiating Clones Derived from Marrow

  1967cited by this paper

• Scrutinizing the role of aqueous extract of Trapa bispinosa as an immunomodulator in experimental animals

  2016cites this paper
• Comparative phytochemical analysis and in vivo immunomodulatory activity of various extracts of Stevia rebaudiana leaves in experimental animal model

  2015cites this paper
• Plants as potential sources of natural immunomodulators

  2014cites this paper
• Biotechnological Approach to Evaluate the Immunomodulatory Activity of Ethanolic Extract of Tinospora cordifolia Stem (Mango Plant Climber)

  2012cites this paper
• A polyherbal ayurvedic drug--Indukantha Ghritha as an adjuvant to cancer chemotherapy via immunomodulation.

  2008cites this paper
• In vitro effects of 4-hydroperoxycyclophosphamide on concanavalin A-induced human suppressor T cells

  2004cites this paper
• Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation.

  1999cites this paper
• Studies on the immunomodulatory effects of Ashwagandha.

  1996cites this paper
• Inhibition of T suppressor cell function by local administration of an active cyclophosphamide derivative at the sensitization site.

  1991cites this paper
• [The effect of the complex platinum (IV) compound oxoplatinum on the immune system].

  1990cites this paper
• Characterization and Functions of the Natural Suppressor Cell Systems

  1989cites this paper
• Intravenous cyclophosphamide therapy of severe SLE.

  1989cites this paper
• Lethal vaccinia infection in cyclophosphamide-suppressed mice is associated with decreased expression of Thy-1, Lyt-2 and L3T4 and diminished IL-2 production in surviving T cells.

  1988cites this paper
• The effect of cyclophosphamide on B cells and 'background' immunoglobulin-secreting cells in mice.

  1988cites this paper
• The Pharmacology of Lymphocytes

  1988cites this paper
• Effects of adriamycin, 4-hydroperoxycyclophosphamide and ASTA Z 7557 (INN mafosfamide) on the release of IL-2 and IL-1 in vitro.

  1987cites this paper
• In vitro effects of 4-hydroxyperoxycyclophosphamide on human immunoregulatory T subset function.

  1987cites this paper
• [Action of cyclophosphane and degranol on the T- and B-lymphocyte populations in the lymph nodes when administered endolymphatically].

  1986cites this paper
• Long-lasting enhancement of the delayed-type hypersensitivity response to heterologous erythrocytes in mice after a single injection of cyclophosphamide.

  1986cites this paper
• Organophosphorus drugs (Review)

  1985cites this paper
• A critical review of the literature on acrolein toxicity.

  1985cites this paper
• Studies on lipopolysaccharide-induced polyclonal B cell activity in mice tolerized by sheep red blood cells and cyclophosphamide.

  1985cites this paper
• Sensitivity to immunodepressant action of cyclophosphamide: analysis of interstrain differences in mice.

  1985cites this paper
• Immunoregulation by Cancer Chemotherapeutic Agents

  1985cites this paper
• Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders.

  1985cites this paper
• Dose-response effects of 4-hydroperoxycyclophosphamide on human T and B cell function in vitro.

  1985cites this paper
• Inhibition of proliferation without affecting the generation of cytotoxicity in the human mixed lymphocyte reaction.

  1985cites this paper
• Resistance to 4-hydroperoxycyclophosphamide of T cells involved in cell mediated antibacterial immunity.

  1984cites this paper
• Immunology in drug research.

  1984cites this paper
• Immunologic insights into uveitis and retinitis: the immunoregulatory circuit.

  1984cites this paper
• Effects of chemotherapeutic agents on the immune response. I.

  1984cites this paper
• Immunomodulation by Cyclophosphamide

  1984cites this paper
• IMMUNOMODULATING INFLUENCE OF ACTIVE METABOLITE OF CYCLOPHOSPHAMIDE ON HUMAN LYMPHOCYTE IMMUNOGLOBULIN BIOSYNTHESIS IN VITRO

  1983cites this paper
• Effects of cyclophosphamide on autoantibody synthesis in the Brown Norway rat.

  1983cites this paper
• Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases.

  1983cites this paper
• Comparative study on the immunosuppressive and lympholytic activity of optical isomers of cyclophosphamide.

  1983cites this paper
• In vitro alteration of canine renal allografts with cyclophosphamide metabolites.

  1983cites this paper
• In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration

  1982cites this paper
• Cloning of African trypanosomes in mice immunosuppressed by cyclophosphamide treatment.

  1982cites this paper
• Functionally sensitive and resistant populations of lymphoid cells from normal and mammary tumor bearing mice following treatment with cyclophosphamide.

  1982cites this paper
• The mechanism of tumor allograft survival induced by CP-17,193.

  1982cites this paper
• Immunosuppressive Agents—Their Action on Inductive and Regulatory Pathways

  1982cites this paper
• Induction and persistence of B-cell tolerance to the thymus-dependent component of the alpha(1 leads to 6) glucosyl determinant of dextran. Recovery induced by treatment with dextranase in vivo.

  1981cites this paper
• A STUDY ON THE MECHANISM OF DONOR PRETREATMENT EFFECT OF PROCARBAZINE HYDROCHLORIDE AND METHYLPREDNISOLONE ON IMMUNOCOMPETENT CELLS

  1981cites this paper
• Detection of Cocarcinogens and Anticarcinogens with Microbial Mutagenicity Assays

  1981cites this paper
• Direct in vitro evidence for different susceptibilities to 4-hydroperoxycyclophosphamide of antigen-primed T cells regulating humoral and cell-mediated immune responses to sheep erythrocytes: a possible explanation for the inverse action of cyclophosphamide on humoral and cell-mediated immune respon

  1981cites this paper
• Suppressor Cells and the Handling of Antigen

  1980cites this paper
• Effect of Anti-Parasite Chemotherapeutic Agents on Immune Reactions.

  1980cites this paper
• Differential sensitivity to cyclophosphamide of helper T cells for humoral responses and suppressor T cells for delayed‐type hypersensitivity

  1980cites this paper
• Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide.

  1980cites this paper
• Different susceptibilities to 4-hydroperoxycyclophosphamide of T cell sub-sets involved in delayed-type hypersensitivity of mice to sheep red blood cells

  1980cites this paper
• T-suppressor cells sensitive to cyclophosphamide and to its in vitro active derivative 4-hydroperoxycyclophosphamide control the mitogenic response of murine splenic B cells to dextran sulfate. A direct proof for different sensitivities of lymphocyte subsets to cyclophosphamide

  1979influential citation
• The immunopharmacology of cyclophosphamide.

  1979cites this paper
• The Nature of Drug‐Induced B Cell Tolerance

  1979cites this paper